bcr_patient_barcode	bcr_drug_barcode	bcr_drug_uuid	clinical_trail_drug_classification	date_of_form_completion	days_to_drug_therapy_end	days_to_drug_therapy_start	drug_name	measure_of_response	number_cycles	prescribed_dose	prescribed_dose_units	regimen_indication	regimen_indication_notes	regimen_number	route_of_administration	therapy_ongoing	therapy_type	therapy_type_notes	total_dose	total_dose_units	tx_on_clinical_trial
TCGA-A6-2671	TCGA-A6-2671-D12768	2887faa4-89f4-40e5-ab43-8cbc7095ac80	[Not Available]	2011-6-7	711	550	Irinotecan	[Not Available]	9	300-320	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2890	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D12770	9859896f-c740-4094-96ad-102b312c4b6b	[Not Available]	2011-6-7	753	550	5 FU	[Not Available]	13	725	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9425	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D12771	7c651876-aff7-4947-9797-98c908dd30e4	[Not Available]	2011-6-7	755	550	5FU	[Not Available]	13	4300-4325	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	56000	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D12772	6d5ce679-235e-463c-85a8-d6812506f399	[Not Available]	2011-6-7	753	725	Leucovorin	[Not Available]	3	500	mg	PROGRESSION	[Not Applicable]	2	Intravesical	NO	Other, specify	Ancillary	1500	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D12773	e0b656ab-0cd3-4cd5-84d9-919225e636f2	[Not Available]	2011-6-7	738	550	Avastin	[Not Available]	12	300-325	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	3775	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D31097	3254ea81-298b-461f-9e51-2daa00fb9c60	[Not Available]	2012-4-24	984	843	Irinotecan	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D31177	28b4628d-26ff-4ffe-998d-3a1de2be56b8	[Not Available]	2012-4-24	843	843	5-FU	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D31178	9ef7c5d5-470f-4586-8ff2-adb6b1db8667	[Not Available]	2012-4-24	843	843	Leucovorin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Ancillary	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D31179	0b9b3648-918f-4f14-a9c8-5cd58d935ed7	[Not Available]	2012-4-24	845	843	5-FU	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D31180	386e2918-33c5-4df0-a196-28864d9a87e3	[Not Available]	2012-4-24	984	843	Avastin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D31182	b57bfe0a-f932-417b-b510-dc6c1800c1a7	[Not Available]	2012-4-24	1104	1041	Irinotecan	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D31184	f8603c4a-b9ed-4efa-a9d1-07b84ae5c330	[Not Available]	2012-4-24	1091	1041	Erbitux	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-2671	TCGA-A6-2671-D6020	3aefce87-3734-4b5f-a4e2-c62dbba5badf	[Not Available]	2011-1-11	270	95	Study drug AMG 655	[Not Available]	12	[Not Available]	mg/kg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Protocol AMG 20060464	[Not Available]	mg/kg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6025	b7b6c0f7-bf3f-45c3-b847-79b03842ba16	[Not Available]	2011-1-12	270	95	Avastin	[Not Available]	12	300-320	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	3620	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6046	c8f771fa-6176-48de-8426-1f572f7866d8	[Not Available]	2011-1-12	185	95	Oxaliplatin	[Not Available]	7	115-155	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	985	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6049	891f0411-bdcc-468d-bc50-acc539d6bc11	[Not Available]	2011-1-12	270	95	Leucovorin	[Not Available]	12	700-735	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	8435	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6051	25d52ff6-0b91-435d-8fc0-dcdc5519fa81	[Not Available]	2011-1-12	272	95	5 FU	[Not Available]	12	2650-4400	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	42950	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6055	409b319f-5642-4f38-8e5d-d948107d0425	[Not Available]	2011-1-12	270	95	5 FU	[Not Available]	12	450-735	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7185	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6056	4c5e40d8-6a8a-4638-8b23-2461b1dcdd79	[Not Available]	2011-1-12	[Not Available]	550	Avastin	[Not Available]	7	300-325	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	YES	Targeted Molecular therapy	[Not Available]	2200	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6059	dc9ad6a9-f324-4d56-93ae-dad6cd659a43	[Not Available]	2011-1-12	[Not Available]	550	Irinotecan	[Not Available]	7	320-325	mg	PROGRESSION	[Not Applicable]	1	Intravenous (IV)	YES	Chemotherapy	[Not Available]	2250	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6091	75929a1b-da0b-4859-9592-e0b096b3e46c	[Not Available]	2011-1-12	[Not Available]	550	5 FU	[Not Available]	7	725	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	YES	Chemotherapy	[Not Available]	5075	mg	[Not Available]
TCGA-A6-2671	TCGA-A6-2671-D6092	fdda207f-5b42-4d35-87bc-c3156b31312d	[Not Available]	2011-1-12	[Not Available]	550	5 FU	[Not Available]	7	4300-4325	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	YES	Chemotherapy	[Not Available]	30200	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D18366	13dd3946-99d8-43e0-b529-b79140588e52	[Not Available]	2011-11-14	944	761	Bevacizumab	[Not Available]	12	400-448	mg	RECURRENCE	[Not Applicable]	2	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	5173	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D18367	ba5c0262-3fbf-4e10-b18e-6d74b224da07	[Not Available]	2011-11-14	944	761	Oxaliplatin	[Not Available]	12	173-177	mg	RECURRENCE	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2093	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D18368	3779457f-da47-48bc-bb01-e9f988c8a6fc	[Not Available]	2011-11-14	944	761	Leucovorin	[Not Available]	12	50-800	mg	RECURRENCE	[Not Applicable]	2	Intravenous (IV)	NO	Other, specify	ancillary	1750	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D18369	a127ba7d-746f-46df-a7e8-d89a4a9945b6	[Not Available]	2011-11-14	944	761	Fluorouracil	[Not Available]	12	812-832	mg	RECURRENCE	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9852	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D18370	a2845a5c-66f7-4f7e-879d-33b8d06cb6ba	[Not Available]	2011-11-14	946	761	Fluorouracil	[Not Available]	12	4872-4992	mg	RECURRENCE	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	59112	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D4947	365ae66b-f33f-45f3-8894-0ad421609e63	[Not Available]	2010-10-15	237	75	Oxaliplatin	[Not Available]	12	170	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1950	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D4948	b5b3adc2-ffb4-480a-866c-996bf91eed24	[Not Available]	2010-10-15	237	75	Levcovorin	[Not Available]	12	800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	9150	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D4949	5022a88e-849c-499e-8708-80ef8f39165c	[Not Available]	2010-10-15	237	75	5 FU	[Not Available]	12	800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9150	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D4951	5a028017-d8ab-465a-8dca-6416332d59d8	[Not Available]	2010-10-15	239	75	5 FU	[Not Available]	12	4800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	54600	mg	[Not Available]
TCGA-A6-2674	TCGA-A6-2674-D4952	3ce98d9a-0b40-4e25-9ba2-58794d288247	[Not Available]	2010-10-15	237	90	Avastin	[Not Available]	10	440	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	4400	mg	[Not Available]
TCGA-A6-2676	TCGA-A6-2676-D2538	6c3085ac-6d53-49fe-a8c0-4585b9ae2945	[Not Available]	2010-10-25	111	76	Oxaliplatin	[Not Available]	3	116-122	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	360	mg	[Not Available]
TCGA-A6-2676	TCGA-A6-2676-D2539	716560b1-bfca-4513-9253-66e8ce01bffa	[Not Available]	2010-10-25	111	76	5- FU	[Not Available]	3	461-576	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1581	mg	[Not Available]
TCGA-A6-2676	TCGA-A6-2676-D2540	5b1553bb-4c01-431e-b6c3-32fd8f32636b	[Not Available]	2010-10-25	111	76	Leucovorin	[Not Available]	3	550-600	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	1750	mg	[Not Available]
TCGA-A6-2676	TCGA-A6-2676-D2541	108e080e-0872-4a94-9b2a-b8990dc5b718	[Not Available]	2010-10-25	113	76	5-FU	[Not Available]	3	2765-3456	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9485	mg	[Not Available]
TCGA-A6-2677	TCGA-A6-2677-D2510	07c7b730-6602-4b6b-bb72-99d5b986f227	[Not Available]	2010-10-21	252	112	Oxaliplatin	[Not Available]	9	66-150	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	976	mg	[Not Available]
TCGA-A6-2677	TCGA-A6-2677-D2514	fc790e21-4b95-4088-b256-6f1f47d9e46f	[Not Available]	2010-10-21	617	112	5- FU	[Not Available]	9	592-620	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	5504	mg	[Not Available]
TCGA-A6-2677	TCGA-A6-2677-D2516	8bcbb764-ba22-4dca-98cb-b56141536845	[Not Available]	2010-10-21	617	112	Leucovorin	[Not Available]	9	600	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	5400	mg	[Not Available]
TCGA-A6-2677	TCGA-A6-2677-D2518	f63c40b8-a6dc-4a65-b2ed-e7b458fd120a	[Not Available]	2010-10-21	252	112	5-FU	[Not Available]	9	3552-3720	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	33,024	mg	[Not Available]
TCGA-A6-2678	TCGA-A6-2678-D2527	203e134c-6cea-4850-85fb-61d0590d6783	[Not Available]	2010-10-25	214	60	Oxaliplatin	[Not Available]	12	100-170	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1531	mg	[Not Available]
TCGA-A6-2678	TCGA-A6-2678-D2528	62fa0dfa-21c9-4bbf-b910-f7f695e7f169	[Not Available]	2010-10-25	214	60	5- FU	[Not Available]	12	776-804	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9588	mg	[Not Available]
TCGA-A6-2678	TCGA-A6-2678-D2529	a47a2727-c80a-47bf-82e3-43613c0f7535	[Not Available]	2010-10-25	214	60	5- FU	[Not Available]	12	4656-4872	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	57528	mg	[Not Available]
TCGA-A6-2678	TCGA-A6-2678-D2530	b23a79b4-3671-4ae4-8a1b-461b91a9de9a	[Not Available]	2010-10-25	214	60	Leucovorin	[Not Available]	12	800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	9600	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6905	06febf7e-3cba-45b5-a1fb-b6935217ea74	[Not Available]	2011-1-28	106	43	Oxaliplatin	[Not Available]	5	100-178	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	783	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6906	f0e8ad72-519f-4d7a-806d-4c861525fef7	[Not Available]	2011-1-28	106	43	Leucovorin	[Not Available]	5	400-850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	3350	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6907	22f90f8f-9bd8-4e02-b69d-306207facef8	[Not Available]	2011-1-28	106	43	5 FU	[Not Available]	5	400-836	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3310	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6908	6d41c707-6c72-4ead-9e68-6677b9ae902d	[Not Available]	2011-2-1	108	43	5 FU	[Not Available]	5	2000-5000	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	19,021	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6909	450d6b36-99fe-499b-93bc-548de8a785d9	[Not Available]	2011-1-28	282	231	Oxaliplatin	[Not Available]	4	89-182	mg	ADJUVANT	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	631	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6910	6daa7738-34ec-47e4-b489-6b1935932b6d	[Not Available]	2011-1-28	282	231	5 FU	[Not Available]	4	420-856	mg	ADJUVANT	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2972	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6911	273a2571-4f64-4350-b5d6-02ac929b2184	[Not Available]	2011-1-28	282	231	Leucovorin	[Not Available]	4	400-850	mg	ADJUVANT	[Not Applicable]	2	Intravenous (IV)	NO	Other, specify	Ancillary	2950	mg	[Not Available]
TCGA-A6-2682	TCGA-A6-2682-D6912	ce77ae94-e1dc-41e4-989a-8891fd070a58	[Not Available]	2011-2-1	284	231	5 FU	[Not Available]	4	2500-5136	mg	ADJUVANT	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	17812	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4960	0b8a83b5-8223-41a9-b90f-e9b2b1a54ae8	[Not Available]	2010-10-18	287	48	5 FU	[Not Available]	16	625	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10050	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4961	8e1fe263-78d0-40af-a3a7-8cb7a9185893	[Not Available]	2010-10-18	287	48	Levcovorin	[Not Available]	16	625	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	10050	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4962	1f797061-446e-4ba7-8117-30d480a8de8a	[Not Available]	2010-10-18	289	48	5 FU	[Not Available]	16	4000	mg	ADJUVANT	[Not Applicable]	1	[Not Available]	NO	Chemotherapy	[Not Available]	60525	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4963	da116895-1b80-4709-94ed-70230241fc46	[Not Available]	2010-10-18	287	105	Avastin	[Not Available]	12	275	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	3210	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4964	055caca7-c379-485e-8fa9-9f66029b7acb	[Not Available]	2010-10-18	350	322	Oxaliplatin	[Not Available]	3	140	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	420	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4966	616c70ed-f4d1-4ac8-bcd5-95fb57094d0a	[Not Available]	2010-10-18	350	322	5 FU	[Not Available]	3	650	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1950	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4967	b7e6fdf1-0994-4881-8f03-6dcd65d58c18	[Not Available]	2010-10-18	350	322	Leucovorin	[Not Available]	3	650	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Other, specify	Ancillary Agent	1950	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4968	62e33cf5-3a37-43dc-8fdb-c2258a9c910b	[Not Available]	2010-10-18	352	322	5 FU	[Not Available]	3	3950	mg	PROGRESSION	[Not Applicable]	2	[Not Available]	NO	Chemotherapy	[Not Available]	11850	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4969	6a41add5-5273-4d56-b4b0-6b9065dd9ddf	[Not Available]	2010-10-18	350	322	Avastin	[Not Available]	3	300	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	900	mg	[Not Available]
TCGA-A6-2683	TCGA-A6-2683-D4970	e3bedc74-6ed7-4959-8d5c-fb6ccfc417a5	[Not Available]	2010-10-18	443	443	Mitomycin C	[Not Available]	1	16	mg	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	16	mg	[Not Available]
TCGA-A6-3807	TCGA-A6-3807-D2547	5ef50513-5321-43a8-bc76-7532cf293e1c	[Not Available]	2010-10-26	241	74	Oxaliplatin	[Not Available]	12	100-195	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1295	mg	[Not Available]
TCGA-A6-3807	TCGA-A6-3807-D2548	96c56ecc-18dd-4d47-9052-82db0bb3e1b6	[Not Available]	2010-10-26	241	74	Leucovorin	[Not Available]	12	360-925	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	5515	mg	[Not Available]
TCGA-A6-3807	TCGA-A6-3807-D2549	ed12b670-cdaf-487d-823f-f127a5dae4ed	[Not Available]	2010-10-26	241	74	5-FU	[Not Available]	12	360-925	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	5515	mg	[Not Available]
TCGA-A6-3807	TCGA-A6-3807-D2550	4a311e57-72d6-43e9-8b60-bd0c5e8c7bb6	[Not Available]	2010-10-26	243	74	5 FU	[Not Available]	12	2150-5500	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	33,350	mg	[Not Available]
TCGA-A6-4107	TCGA-A6-4107-D7151	4e2c6d3a-81e4-478e-9011-aa1486b9be7b	[Not Available]	2011-2-4	197	50	Oxaliplatin	[Not Available]	11	77-160	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1414	mg	[Not Available]
TCGA-A6-4107	TCGA-A6-4107-D7158	f448b097-dfa4-4115-9bcc-0bfb694afc51	[Not Available]	2011-2-4	197	50	Leucovorin	[Not Available]	11	50-750	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	4050	mg	[Not Available]
TCGA-A6-4107	TCGA-A6-4107-D7159	fc232b41-59b3-4ad0-a64c-ec240b773181	[Not Available]	2011-2-4	197	50	5 FU	[Not Available]	11	546-752	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7800	mg	[Not Available]
TCGA-A6-4107	TCGA-A6-4107-D7160	efcd9394-67ff-45db-a8c8-2a14eafa65f6	[Not Available]	2011-2-4	199	50	5 FU	[Not Available]	11	3276-4512	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	46800	mg	[Not Available]
TCGA-A6-5657	TCGA-A6-5657-D12384	acfd75b3-5851-4076-9e2d-847babf77bf1	[Not Available]	2011-5-31	54	40	Oxaliplatin	[Not Available]	1	178-179	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	357	mg	[Not Available]
TCGA-A6-5657	TCGA-A6-5657-D12385	06252ba3-ef9d-4962-b9fe-71a2a400610b	[Not Available]	2011-5-31	54	40	5 FU	[Not Available]	1	1000-1055	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3055	mg	[Not Available]
TCGA-A6-5657	TCGA-A6-5657-D12386	5c18e079-5a69-4390-b00f-e806fc54ad99	[Not Available]	2011-5-31	54	40	Leucovorin	[Not Available]	1	1000-1050	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Leucovorin	3050	mg	[Not Available]
TCGA-A6-5660	TCGA-A6-5660-D12415	609032be-e6d6-428c-909f-f0ba7b2bf342	[Not Available]	2011-6-1	201	82	Oxaliplatin	[Not Available]	9	131-173	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1509	mg	[Not Available]
TCGA-A6-5660	TCGA-A6-5660-D12418	ef6fde9e-c1b4-4576-aacb-a8869a522738	[Not Available]	2011-6-1	243	82	5FU	[Not Available]	12	804-820	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9752	mg	[Not Available]
TCGA-A6-5660	TCGA-A6-5660-D12432	75cb6eb3-4e9a-421e-a611-3bb290130d80	[Not Available]	2011-6-1	245	82	5 FU	[Not Available]	12	4824-4920	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	58512	mg	[Not Available]
TCGA-A6-5660	TCGA-A6-5660-D12435	5f1e45b0-0859-4efb-a7e5-efb825e22fc3	[Not Available]	2011-6-1	243	82	Leucovorin	[Not Available]	12	50-800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	1350	mg	[Not Available]
TCGA-A6-5662	TCGA-A6-5662-D18214	bb925bf4-00b9-42dd-93aa-ee0576cc19ef	[Not Available]	2011-11-8	368	60	Oxaliplatin	[Not Available]	12	143-171	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1977	mg	[Not Available]
TCGA-A6-5662	TCGA-A6-5662-D18215	1caf1e4f-8aaa-43dc-9348-55b58fd5729e	[Not Available]	2011-11-8	395	60	Fluorouracil	[Not Available]	23	487-804	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	17194	mg	[Not Available]
TCGA-A6-5662	TCGA-A6-5662-D18217	ae0bab42-dcdf-4839-8310-26e7971cb270	[Not Available]	2011-11-8	395	60	Leucovorin	[Not Available]	23	50-100	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Other, specify	Ancillary	1450	mg	[Not Available]
TCGA-A6-5662	TCGA-A6-5662-D18218	33f69924-19e0-446d-8b33-b9e5d327e610	[Not Available]	2011-11-8	397	60	Fluorouracil	[Not Available]	23	2923-4824	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	101,059	mg	[Not Available]
TCGA-A6-5662	TCGA-A6-5662-D18219	4ac04901-5785-41aa-9367-81ac00bfa8be	[Not Available]	2011-11-8	395	60	Bevacizumab	[Not Available]	23	389-436	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	9488	mg	[Not Available]
TCGA-A6-5662	TCGA-A6-5662-D18220	00bf24a2-d995-4f9e-8c7f-8603f0c9c582	[Not Available]	2011-11-8	488	427	Xeloda	[Not Available]	3	3500- 4000	mg	OTHER: SPECIFY IN NOTES	Metastatic	2	Oral	NO	Chemotherapy	[Not Available]	[Not Available]	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15774	cee020b0-05cb-4773-86d0-24f266a4c239	[Not Available]	2011-8-31	273	231	Oxaliplatin	[Not Available]	4	150	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	600	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15775	2e02ab32-cfd5-4435-9bbb-d0d5cd74e318	[Not Available]	2011-8-31	273	231	Leucovorin	[Not Available]	4	50-100	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	300	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15776	3b3a45ac-d472-4def-ba9b-d3b9b9b128ed	[Not Available]	2011-8-31	275	231	Fluorouracil	[Not Available]	4	4392-4416	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	17664	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15777	fb3b27ca-4360-4a50-ba63-27801b3a2451	[Not Available]	2011-8-31	259	231	Bevacizumab	[Not Available]	3	334-343	mg	PALLIATIVE	[Not Applicable]	1	Intravenous (IV)	NO	Targeted Molecular therapy	[Not Available]	1016	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15804	c3a8627d-8872-491d-a670-a382c96334f2	[Not Available]	2011-9-1	[Not Available]	301	Irinotecan	[Not Available]	4	320-331	mg	PALLIATIVE	[Not Applicable]	2	Intravenous (IV)	YES	Chemotherapy	[Not Available]	1313	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15809	24d21731-0c40-44e8-8a1b-f6317f78b0d2	[Not Available]	2011-9-1	[Not Available]	301	Bevacizumab	[Not Available]	1	339	mg	PALLIATIVE	[Not Applicable]	2	Intravenous (IV)	YES	Targeted Molecular therapy	[Not Available]	339	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15810	e2446b99-586f-4a4a-bdac-86b3baa79ee1	[Not Available]	2011-9-1	[Not Available]	301	Leucovorin	[Not Available]	4	50-150	mg	PALLIATIVE	[Not Applicable]	2	Intravenous (IV)	YES	Other, specify	Ancillary	400	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15811	dc3ca0c7-d4f6-4569-9e6a-3ab0421a3c62	[Not Available]	2011-9-1	[Not Available]	301	Fluorouracil	[Not Available]	4	736	mg	PALLIATIVE	[Not Applicable]	2	Intravenous (IV)	YES	Chemotherapy	[Not Available]	2944	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D15812	7cad8852-e503-4c95-a4f7-ca6c11e54542	[Not Available]	2011-9-1	[Not Available]	301	Fluorouracil	[Not Available]	4	4416	mg	PALLIATIVE	[Not Applicable]	2	Intravenous (IV)	YES	Chemotherapy	[Not Available]	17664	mg	[Not Available]
TCGA-A6-5664	TCGA-A6-5664-D33770	3BA99B8C-D023-41EB-BD42-E479F3EBDEDF	[Not Available]	2012-7-16	635	301	Irinotecan	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-5664	TCGA-A6-5664-D33771	07B9A3D8-5A9A-42A5-9C94-C102D4CFE178	[Not Available]	2012-7-16	391	301	Bevacizumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-5664	TCGA-A6-5664-D33772	8249DBD2-17BC-46F8-BF68-4FF5E4D0BA0A	[Not Available]	2012-7-16	635	301	Leucovorin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Ancillary	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-5664	TCGA-A6-5664-D33773	AE58752C-D8C7-469A-A65B-72ABF738364E	[Not Available]	2012-7-16	635	301	Fluorouracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-5664	TCGA-A6-5664-D33774	D8CFB903-4B53-4FDB-B226-2893791A7ADF	[Not Available]	2012-7-16	637	301	Fluorouracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-A6-5667	TCGA-A6-5667-D13423	db0386f8-b893-4fa3-bd66-33eac054e066	[Not Available]	2011-6-27	160	62	Oxaliplatin	[Not Available]	8	100-158	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1026	mg	[Not Available]
TCGA-A6-5667	TCGA-A6-5667-D13424	1f9e7cb8-aa9f-439d-b187-ba5f32ace987	[Not Available]	2011-6-27	223	62	5 FU	[Not Available]	12	662-744	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	8674	mg	[Not Available]
TCGA-A6-5667	TCGA-A6-5667-D13426	b3dc8aab-d46f-4239-b2fa-2050e3721e71	[Not Available]	2011-6-27	223	62	Leucovorin	[Not Available]	12	50-125	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	925	mg	[Not Available]
TCGA-A6-5667	TCGA-A6-5667-D13429	70fb07b7-8554-46f0-b865-ad8979c5ddba	[Not Available]	2011-6-27	225	62	5FU	[Not Available]	12	3974-4464	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	52044	mg	[Not Available]
TCGA-A6-6137	TCGA-A6-6137-D18039	2c4dc053-3db9-4821-8c56-1a278c580100	[Not Available]	2011-11-3	211	28	Oxaliplatin	[Not Available]	3	177-182	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1619	mg	[Not Available]
TCGA-A6-6137	TCGA-A6-6137-D18041	49b125ba-8d58-4fcc-8642-e6904a9d2eea	[Not Available]	2011-11-3	218	28	Fluorouracil	[Not Available]	3	1000-1070	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	18070	mg	[Not Available]
TCGA-A6-6137	TCGA-A6-6137-D18042	2b2b0da3-33bf-4d8f-bb44-a404410e818d	[Not Available]	2011-11-3	218	28	Leucovorin	[Not Available]	3	50-200	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	1450	mg	[Not Available]
TCGA-A6-6140	TCGA-A6-6140-D20354	ba8de936-a9ae-4858-ba46-6e682ed17c82	[Not Available]	2012-1-9	180	34	Oxaliplatin	[Not Available]	3	83-163	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	985	mg	[Not Available]
TCGA-A6-6140	TCGA-A6-6140-D20355	555b9c92-b76f-4e07-8f57-cde03e8e773d	[Not Available]	2012-1-9	187	34	Fluorouracil	[Not Available]	3	720-960	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	13801	mg	[Not Available]
TCGA-A6-6140	TCGA-A6-6140-D20356	25c8886e-fa04-4b3a-ab0a-ed022afa6405	[Not Available]	2012-1-9	187	34	Leucovorin	[Not Available]	3	50-175	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	1525	mg	[Not Available]
TCGA-A6-6141	TCGA-A6-6141-D21501	f3ddb88f-1ac9-4fe8-99c0-9c299af34ae0	[Not Available]	2012-2-14	213	59	Oxaliplatin	[Not Available]	12	180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2160	mg	[Not Available]
TCGA-A6-6141	TCGA-A6-6141-D21502	7fd0f190-15dc-4f21-bd5a-4b7a10378e8a	[Not Available]	2012-2-14	213	59	Leucovorin	[Not Available]	12	550	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	4900	mg	[Not Available]
TCGA-A6-6141	TCGA-A6-6141-D21503	9b6fffa2-0197-4e5d-83b7-6799693aecb7	[Not Available]	2012-2-14	213	59	5FU	[Not Available]	12	850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10200	mg	[Not Available]
TCGA-A6-6141	TCGA-A6-6141-D21504	268e1286-26c0-4536-9f42-c7f5ea328d67	[Not Available]	2012-2-14	215	59	5FU	[Not Available]	12	5150	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	61800	mg	[Not Available]
TCGA-A6-6142	TCGA-A6-6142-D28726	e3ae1ca9-0fc8-416c-b5b0-5b3bbebdb77b	[Not Available]	2012-2-28	338	141	Oxaliplatin	[Not Available]	12	95-150	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1501	mg	[Not Available]
TCGA-A6-6142	TCGA-A6-6142-D28727	698bfec7-fb37-43b9-aa00-8567f13f8a4a	[Not Available]	2012-2-28	338	141	Leucovorin	[Not Available]	12	50-752	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	5048	mg	[Not Available]
TCGA-A6-6142	TCGA-A6-6142-D28729	50512b15-54bb-4a84-b660-746ec73824f5	[Not Available]	2012-2-28	338	141	Fluorouracil	[Not Available]	12	494-752	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7545	mg	[Not Available]
TCGA-A6-6142	TCGA-A6-6142-D28730	16ab0b29-4834-4c89-aac1-63c46bbc2872	[Not Available]	2012-2-26	340	141	Fluorouracil	[Not Available]	12	2850-4512	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	44695	mg	[Not Available]
TCGA-A6-6648	TCGA-A6-6648-D17989	a356522b-2132-46f8-a9d8-7c380201e8ba	[Not Available]	2011-11-1	77	63	Cetuximab Study drug	[Not Available]	1	1050	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Other, specify	Clinical Trial	[Not Available]	mg	[Not Available]
TCGA-A6-6648	TCGA-A6-6648-D17990	999f6885-13bd-4180-ac46-94bb3a6e01e1	[Not Available]	2011-11-1	91	63	Oxaliplatin	[Not Available]	1	180	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Other, specify	Clinical Trial	540	mg	[Not Available]
TCGA-A6-6648	TCGA-A6-6648-D17991	4786b23e-8b48-48c6-bfee-d431500e366a	[Not Available]	2011-11-1	91	63	Leucovorin	[Not Available]	1	840-850	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Other, specify	Clinical Trial	2540	mg	[Not Available]
TCGA-A6-6648	TCGA-A6-6648-D17992	186076eb-7755-4b35-8e49-fd1156a8beea	[Not Available]	2011-11-1	93	63	5 FU	[Not Available]	1	6300	mg	OTHER: SPECIFY IN NOTES	Metastatic	1	Intravenous (IV)	NO	Other, specify	Clinical trial	18900	mg	[Not Available]
TCGA-A6-6649	TCGA-A6-6649-D19131	b90ac8b4-29d6-490c-bacc-1b28fc09e6ca	[Not Available]	2011-12-2	68	68	Oxaliplatin	[Not Available]	1	197	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	197	mg	[Not Available]
TCGA-A6-6649	TCGA-A6-6649-D19132	e68051a4-b42e-43a5-9114-81f73b2852ff	[Not Available]	2011-12-2	144	68	Fluorouracil	[Not Available]	6	664-948	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	4713	mg	[Not Available]
TCGA-A6-6649	TCGA-A6-6649-D19161	6d48ab98-3956-42ff-b409-3acaa4fe5334	[Not Available]	2011-12-5	146	68	Fluorouracil	[Not Available]	6	3982-5688	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	28277	mg	[Not Available]
TCGA-A6-6649	TCGA-A6-6649-D19176	5a80c12d-0cbd-4019-9d7c-d07152df3d3d	[Not Available]	2011-12-5	144	68	Leucovorin	[Not Available]	6	50-175	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	575	mg	[Not Available]
TCGA-A6-6651	TCGA-A6-6651-D18527	8ab6ac64-e947-4bbd-85c6-2e8d7b472d87	[Not Available]	2011-11-18	204	76	Oxaliplatin	[Not Available]	9	130-164	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1304	mg	[Not Available]
TCGA-A6-6651	TCGA-A6-6651-D18528	a528abe3-9cc5-4833-8f81-9086291a9c00	[Not Available]	2011-11-18	246	76	Leucovorin	[Not Available]	12	50-350	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	1150	mg	[Not Available]
TCGA-A6-6651	TCGA-A6-6651-D18529	74c23414-80cb-4ae3-bcf2-a52122118f4f	[Not Available]	2011-11-18	248	76	Fluorouracil	[Not Available]	12	4560-4704	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	55368	mg	[Not Available]
TCGA-A6-6651	TCGA-A6-6651-D18530	1d1b2876-8f89-4115-a26e-e437e8174fc0	[Not Available]	2011-11-18	246	76	Fluorouracil	[Not Available]	12	760-784	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9228	mg	[Not Available]
TCGA-A6-6652	TCGA-A6-6652-D30459	8eac1749-f057-4382-af62-127ed368dd65	[Not Available]	2012-4-18	[Not Available]	85	Cetuximab	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	YES
TCGA-A6-6652	TCGA-A6-6652-D30907	3a8d9c47-535d-49bc-8901-149af8ad9273	[Not Available]	2012-4-19	253	85	Oxaliplatin	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	YES
TCGA-A6-6652	TCGA-A6-6652-D30908	c13ce170-4baf-4507-9eda-d0f4897f8151	[Not Available]	2012-4-18	[Not Available]	85	Leucovorin	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Ancillary	[Not Available]	[Not Available]	[Not Available]	YES
TCGA-A6-6652	TCGA-A6-6652-D30909	f0c12b8f-7c6f-4be3-8c5e-c2e71bf85879	[Not Available]	2012-4-19	[Not Available]	85	Fluorouracil	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	YES
TCGA-A6-6652	TCGA-A6-6652-D30910	2cfdae08-2b02-48d5-b9ea-12f073efa831	[Not Available]	2012-4-19	[Not Available]	85	Fluorouracil	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	YES
TCGA-A6-6654	TCGA-A6-6654-D29549	85858a5a-2a25-49e2-964e-5508bef1349c	[Not Available]	2012-3-22	275	135	Oxaliplatin	[Not Available]	11	80-180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1640	mg	[Not Available]
TCGA-A6-6654	TCGA-A6-6654-D29785	4904bd04-a129-4cfa-9261-34f59d0ab226	[Not Available]	2012-3-28	290	135	Leucovorin	[Not Available]	12	350-850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	6100	mg	[Not Available]
TCGA-A6-6654	TCGA-A6-6654-D29786	a044ff74-4c3b-4a2e-b545-074c96ff4752	[Not Available]	2012-3-28	290	135	5 FU	[Not Available]	12	800-850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10050	mg	[Not Available]
TCGA-A6-6654	TCGA-A6-6654-D29787	f603532b-fd11-437c-ac3b-3467cf35c2ef	[Not Available]	2012-3-28	292	135	5 FU	[Not Available]	12	4800-5100	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	60300	mg	[Not Available]
TCGA-A6-6781	TCGA-A6-6781-D29217	8bf9874b-b3a3-4f9f-a2fd-d5f1c20afc24	[Not Available]	2012-3-12	158	32	Oxaliplatin	[Not Available]	8	113-189	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1308	mg	[Not Available]
TCGA-A6-6781	TCGA-A6-6781-D29219	c2c8bb68-9f4d-4197-8e3e-b42eb78201c6	[Not Available]	2012-3-12	221	32	Leucovorin	[Not Available]	12	50-900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	2000	mg	[Not Available]
TCGA-A6-6781	TCGA-A6-6781-D29222	d19e09cd-4f33-4fdc-98be-45cb96a40be2	[Not Available]	2012-3-12	221	32	Fluorouracil	[Not Available]	12	872-936	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10832	mg	[Not Available]
TCGA-A6-6781	TCGA-A6-6781-D29223	15555c80-b097-4e8e-a035-7b621c250a15	[Not Available]	2012-3-12	223	32	Fluorouracil	[Not Available]	12	5232-5616	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	64992	mg	[Not Available]
TCGA-AA-3494	TCGA-AA-3494-D37440	96AC2755-D00C-43F2-AF85-250EEE267909	[Not Available]	2012-12-3	184	92	Folinic acid	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3494	TCGA-AA-3494-D37441	22607192-21C1-46B1-9007-82F8207BD46F	[Not Available]	2012-12-3	184	92	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3494	TCGA-AA-3494-D37442	8D724D6C-49CF-4BD7-840D-2DF9295914B5	[Not Available]	2012-12-3	792	184	Capecitabine	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3494	TCGA-AA-3494-D37443	43259854-0480-42D0-98A2-F62606319067	[Not Available]	2012-12-3	334	212	Oxaliplatin	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3494	TCGA-AA-3494-D37444	2F9DDCC4-8761-4EF4-9C8C-9487B219A252	[Not Available]	2012-12-3	1065	334	Irinotecan	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3494	TCGA-AA-3494-D37445	D326355B-264D-4391-9026-C1B14D59A663	[Not Available]	2012-12-3	1065	792	Cetuximab	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3517	TCGA-AA-3517-D37446	4B85C082-B80A-4078-9ACE-04A97F890D2C	[Not Available]	2012-12-3	1065	820	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3517	TCGA-AA-3517-D37447	F87AD537-F5FE-44DB-8AF5-E6409F211742	[Not Available]	2012-12-3	1155	820	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3517	TCGA-AA-3517-D37448	F1363524-2B4B-4BEF-AA3A-4C1332C21770	[Not Available]	2012-12-3	1127	820	Irinotecan	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3517	TCGA-AA-3517-D37449	21ACA8B4-7BE6-4C0B-910C-F3B95A355C06	[Not Available]	2012-12-3	1065	1003	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3517	TCGA-AA-3517-D37450	0DADF926-9A5E-4BB7-A9EF-9122111FAC39	[Not Available]	2012-12-3	1127	820	Bevacizumab	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3542	TCGA-AA-3542-D37453	977CAA41-165B-4CFC-966E-54A9B8400418	[Not Available]	2012-12-3	214	30	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3542	TCGA-AA-3542-D37454	C5B20829-CD88-4658-A64D-378175527DD5	[Not Available]	2012-12-3	214	30	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3542	TCGA-AA-3542-D37455	FA7BF379-E96D-4367-95B2-B00912AE20E1	[Not Available]	2012-12-3	214	30	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3548	TCGA-AA-3548-D37456	93B49DE9-A03F-4B39-B6E3-8BD4788D0490	[Not Available]	2012-12-3	304	31	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3548	TCGA-AA-3548-D37457	F7F32AFA-44B0-4A6A-9750-E45777A0FCE0	[Not Available]	2012-12-3	304	31	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3548	TCGA-AA-3548-D37458	E07A2591-6A1E-4F73-A3D3-516AC60E8D80	[Not Available]	2012-12-3	304	31	Irinotecan	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3560	TCGA-AA-3560-D37463	03F2E068-151A-44F5-A6DD-2D04EC99B0BF	[Not Available]	2012-12-3	211	31	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3560	TCGA-AA-3560-D37464	BADECE76-E2D5-4E8F-AA08-EFAF10FA5EAB	[Not Available]	2012-12-3	211	31	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3560	TCGA-AA-3560-D37465	1791EB2A-6782-4676-B313-4B8F73B36DD0	[Not Available]	2012-12-3	211	31	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3562	TCGA-AA-3562-D37469	2E29FE7B-26FB-403C-A4E4-94AF2131E766	[Not Available]	2012-12-3	242	62	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3562	TCGA-AA-3562-D37470	72A86237-359D-4847-82EA-73CC155CEE90	[Not Available]	2012-12-3	242	62	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3562	TCGA-AA-3562-D37471	F7B983DE-0C58-48A5-A415-655D45D9C330	[Not Available]	2012-12-3	181	62	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3678	TCGA-AA-3678-D37451	A670C33A-E236-4318-9A49-820A1091CD06	[Not Available]	2012-12-3	241	30	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3678	TCGA-AA-3678-D37452	12C68CEF-0CF7-4B84-9CF2-95B80C236707	[Not Available]	2012-12-3	241	30	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3679	TCGA-AA-3679-D37459	190D149A-867E-4A51-AC82-5253C7C98D08	[Not Available]	2012-12-3	[Not Available]	61	Folinic acid	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3679	TCGA-AA-3679-D37460	547AD4AC-2155-44BE-A664-9C74D157121B	[Not Available]	2012-12-3	[Not Available]	61	5-Fluorouracil	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3679	TCGA-AA-3679-D37461	840B021A-FBFE-4ED4-944D-A1B47F95B6A6	[Not Available]	2012-12-3	[Not Available]	61	Irinotecan	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3679	TCGA-AA-3679-D37462	AED3958D-DA22-4743-AE53-4EF7F530F02B	[Not Available]	2012-12-3	[Not Available]	61	Bevacizumab	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3680	TCGA-AA-3680-D37466	CC56A6EE-BBEF-44F2-876A-0AB791B6F9B1	[Not Available]	2012-12-3	90	31	Folinic acid	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3680	TCGA-AA-3680-D37467	60CA88E0-83DA-4B36-BE1D-F18C24A1D8E7	[Not Available]	2012-12-3	90	31	5-Fluorouracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3680	TCGA-AA-3680-D37468	AE2B4E60-C99E-48F0-8B68-5A121C279908	[Not Available]	2012-12-3	90	31	Oxaliplatin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3692	TCGA-AA-3692-D37486	C5BC9915-EBBF-4648-A0FA-9F09297020A2	[Not Available]	2012-12-3	669	31	Folinic acid	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3692	TCGA-AA-3692-D37487	781EDB20-2832-4C12-A42B-CA09749FD454	[Not Available]	2012-12-3	669	31	5-Fluorouracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3692	TCGA-AA-3692-D37488	CFE1096A-3879-429A-8A98-B8F0C2BBD23B	[Not Available]	2012-12-3	883	31	Irinotecan	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3692	TCGA-AA-3692-D37489	FDE51FAB-DA6B-4B36-A1E9-31903F8BBFDA	[Not Available]	2012-12-3	669	31	Bevacizumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3692	TCGA-AA-3692-D37490	086DF84A-9DAF-4E7C-8F35-043714901C01	[Not Available]	2012-12-3	883	883	Cetuximab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3713	TCGA-AA-3713-D37500	9597EA4B-6886-4161-8F9B-825AF0C1FD21	[Not Available]	2012-12-3	455	244	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3841	TCGA-AA-3841-D37472	906C70DA-8292-4D49-8219-0605D0D83B41	[Not Available]	2012-12-3	241	58	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3841	TCGA-AA-3841-D37473	61C33BB9-928A-45B2-9AAE-FE545603CFCF	[Not Available]	2012-12-3	241	58	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3841	TCGA-AA-3841-D37474	4C4944D0-9643-4CFB-9322-92554CEE4DA5	[Not Available]	2012-12-3	241	58	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3842	TCGA-AA-3842-D37475	ADAADEA5-5CC5-4AA4-BA47-150B275E7461	[Not Available]	2012-12-3	211	59	Folinic acid	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3842	TCGA-AA-3842-D37476	8940A6B1-1A17-428B-9929-BD7948D255D9	[Not Available]	2012-12-3	211	59	5-Fluorouracil	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3842	TCGA-AA-3842-D37477	2CE1D74C-9405-46AD-BC26-F102D37AE18D	[Not Available]	2012-12-3	211	59	Oxaliplatin	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3844	TCGA-AA-3844-D37478	44AB9D89-3E3C-461B-ADFD-22214943A595	[Not Available]	2012-12-3	58	58	Capecitabine	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3844	TCGA-AA-3844-D37479	E2943FD1-7025-4ADC-A4C1-E1DA1ABA85AF	[Not Available]	2012-12-3	423	393	Folinic acid	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3844	TCGA-AA-3844-D37480	69922414-9463-4B03-9D7F-D4E028CF5C63	[Not Available]	2012-12-3	423	393	5-Fluorouracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3844	TCGA-AA-3844-D37481	0984FEF0-6099-46AD-9223-E34AFE4BC94C	[Not Available]	2012-12-3	423	393	Oxaliplatin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3844	TCGA-AA-3844-D37482	BAC19AFA-78D6-45CA-B1DB-BC08D71E505E	[Not Available]	2012-12-3	393	393	Bevacizumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3860	TCGA-AA-3860-D37483	A46935F0-B18B-4309-974A-98F5C9843423	[Not Available]	2012-12-3	184	31	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3860	TCGA-AA-3860-D37484	66C6E947-FA93-4F75-B11C-3B9D3AB625D9	[Not Available]	2012-12-3	184	31	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3860	TCGA-AA-3860-D37485	572E00AF-360A-426A-8377-D9A247751050	[Not Available]	2012-12-3	184	31	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3869	TCGA-AA-3869-D37491	DA64549C-BBD5-4E27-B064-182E142FC782	[Not Available]	2012-12-3	365	92	Capecitabine	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3869	TCGA-AA-3869-D37492	ECAD1937-2E65-4E73-959F-DF8DA17FBAD6	[Not Available]	2012-12-3	396	365	Folinic acid	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3869	TCGA-AA-3869-D37493	7BB5F82C-B67C-4405-840E-B5EB1385A49D	[Not Available]	2012-12-3	761	365	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3869	TCGA-AA-3869-D37494	70A670E1-B68A-4FDE-804F-E54569FE7655	[Not Available]	2012-12-3	761	365	Irinotecan	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3869	TCGA-AA-3869-D37495	689C50C2-8AC3-4B58-BA25-84BE69AE99F1	[Not Available]	2012-12-3	580	365	Bevacizumab	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3869	TCGA-AA-3869-D37496	634D660B-99EA-421D-A10D-A9B924C6AB3B	[Not Available]	2012-12-3	761	608	Cetuximab	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3870	TCGA-AA-3870-D37497	A524BF8C-3693-4873-8114-6CC5177E2C3D	[Not Available]	2012-12-3	212	30	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3870	TCGA-AA-3870-D37498	D94292F6-51D0-454D-B608-9D1D674D5981	[Not Available]	2012-12-3	212	30	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3870	TCGA-AA-3870-D37499	C0DDC956-119F-4DAE-B704-8917CA66D803	[Not Available]	2012-12-3	153	30	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3930	TCGA-AA-3930-D37377	7BFAB3A6-37A3-4A3A-9D2D-FF9B6CAE4884	[Not Available]	2012-12-3	31	[Not Available]	Capecitabine	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3955	TCGA-AA-3955-D37378	923A811E-F19F-43E7-84A9-1C1FBA0ABD65	[Not Available]	2012-12-3	180	28	Capecitabine	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3955	TCGA-AA-3955-D37379	CDACF96B-2A58-4F42-8195-990F0E68F7C0	[Not Available]	2012-12-3	149	28	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3967	TCGA-AA-3967-D37420	88E98323-5636-42CA-B3E4-61BD63936922	[Not Available]	2012-12-3	212	59	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3967	TCGA-AA-3967-D37421	ED66B9C8-A20C-4B19-914C-BA8AFC2CB529	[Not Available]	2012-12-3	212	59	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3967	TCGA-AA-3967-D37422	845B10DA-CB7B-4517-ADFB-318C6F3A217E	[Not Available]	2012-12-3	181	89	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3971	TCGA-AA-3971-D37423	5F0380B5-59E5-4BB8-B7AC-1DD2C7E02145	[Not Available]	2012-12-3	215	31	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3971	TCGA-AA-3971-D37424	F71B9357-6613-4BF8-8F2D-9B49B35F1912	[Not Available]	2012-12-3	215	31	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3971	TCGA-AA-3971-D37425	969A32A8-5D14-4A37-9062-DAF425EA1C5B	[Not Available]	2012-12-3	215	31	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3972	TCGA-AA-3972-D37426	45D2A60B-C35E-4BAC-9769-B1D5C0153FED	[Not Available]	2012-12-3	1245	59	Capecitabine	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3972	TCGA-AA-3972-D37427	2DAFDB28-A410-42B2-AF63-E120355C65F7	[Not Available]	2012-12-3	1245	59	Oxaliplatin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3972	TCGA-AA-3972-D37428	DB748C7A-3F23-4440-959F-0652EF839B25	[Not Available]	2012-12-3	1368	1276	Folinic acid	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3972	TCGA-AA-3972-D37429	96844749-3509-4378-99E8-349FDEC7EFE8	[Not Available]	2012-12-3	1368	1276	5-Fluoruoracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3972	TCGA-AA-3972-D37430	A6074E5B-5C69-431C-837C-BFE344753B77	[Not Available]	2012-12-3	1368	1276	Oxaliplatin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3972	TCGA-AA-3972-D37431	D468F9E0-47B4-4132-AD13-0ABB40C4E310	[Not Available]	2012-12-3	1368	1245	Bevacizumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3973	TCGA-AA-3973-D37432	02288D76-A58F-4E92-B19E-08FA0A8A09A3	[Not Available]	2012-12-3	305	31	Folinic acid	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3973	TCGA-AA-3973-D37433	8C12A90B-FDED-4D29-B7FA-DCDA7A730754	[Not Available]	2012-12-3	305	31	5-Fluorouracil	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3973	TCGA-AA-3973-D37434	33052D56-5F11-49F8-BABA-6F23D89EB61D	[Not Available]	2012-12-3	305	31	Irinotecan	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3973	TCGA-AA-3973-D37435	830E21DE-6412-4062-B970-4C321B01D3D4	[Not Available]	2012-12-3	305	[Not Available]	Bevacizumab	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3976	TCGA-AA-3976-D37436	71E44A11-E322-4B4A-9E01-EAA0DA75FD43	[Not Available]	2012-12-3	242	30	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3976	TCGA-AA-3976-D37437	899F6FBF-C49A-43F7-9946-8B8993D26711	[Not Available]	2012-12-3	242	30	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3976	TCGA-AA-3976-D37438	22945031-905D-47E4-814D-EB4815FCF8B5	[Not Available]	2012-12-3	61	30	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-3994	TCGA-AA-3994-D37439	09F57FC8-2E45-4B15-83F1-490E1762A214	[Not Available]	2012-12-3	334	30	Capecitabine	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00F	TCGA-AA-A00F-D37417	A79924C7-E384-46D8-9AA7-C45D0D21E753	[Not Available]	2012-12-3	213	61	Folinic acid	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00F	TCGA-AA-A00F-D37418	41FF725E-E12B-4A08-8828-37F0E889E44E	[Not Available]	2012-12-3	213	61	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00F	TCGA-AA-A00F-D37419	157B2E65-0CA0-485B-9762-7F17FCBD7934	[Not Available]	2012-12-3	213	61	Oxaliplatin	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00J	TCGA-AA-A00J-D37416	B3019D2B-1967-4313-8010-AE45C7D73ADA	[Not Available]	2012-12-3	244	30	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00Q	TCGA-AA-A00Q-D37413	14525E0B-771C-4858-85EA-04411066C462	[Not Available]	2012-12-3	334	61	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00Q	TCGA-AA-A00Q-D37414	551F6AA8-2C03-4ACC-9760-585B262DAC5F	[Not Available]	2012-12-3	334	61	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00Q	TCGA-AA-A00Q-D37415	2FFB89A0-6358-4261-AD46-64CC67C11629	[Not Available]	2012-12-3	334	61	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00U	TCGA-AA-A00U-D37380	573E799A-7A71-49F9-A262-26BF0DCB98ED	[Not Available]	2012-12-3	213	60	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00U	TCGA-AA-A00U-D37381	DD9FE9D1-175B-495F-9E2D-9DF63C15AD70	[Not Available]	2012-12-3	213	60	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A00U	TCGA-AA-A00U-D37382	EA070337-0D97-467F-B588-9F256BE4C9F4	[Not Available]	2012-12-3	213	60	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A010	TCGA-AA-A010-D37410	F4C201FC-604D-4378-BF80-1D0B46DC40EF	[Not Available]	2012-12-3	183	0	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A010	TCGA-AA-A010-D37411	196D63A5-A0C3-4567-B52C-C80754DC5D60	[Not Available]	2012-12-3	183	0	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A010	TCGA-AA-A010-D37412	5E8AE646-9F65-4EE8-BED1-F1874A391471	[Not Available]	2012-12-3	183	0	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01D	TCGA-AA-A01D-D37404	4F739C3B-57E6-4AB5-8F2A-79326FE773E6	[Not Available]	2012-12-3	273	61	Capecitabine	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01D	TCGA-AA-A01D-D37405	C597CB1C-8B1F-4EAE-AACF-2ACB2C0B0267	[Not Available]	2012-12-3	153	61	Oxaliplatin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01D	TCGA-AA-A01D-D37406	9E59767B-446A-4F48-BFEF-20BDB4731B47	[Not Available]	2012-12-3	273	214	Irinotecan	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01D	TCGA-AA-A01D-D37407	F2A4FAE7-D172-454F-8F86-44237D0514DF	[Not Available]	2012-12-3	304	273	Mitomycin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01D	TCGA-AA-A01D-D37408	2F4FDF3B-F5D5-4507-975B-07A38AC4D75C	[Not Available]	2012-12-3	273	214	Bevacizumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01D	TCGA-AA-A01D-D37409	45839A4B-3333-43FE-ABE2-E6FCFE5D837D	[Not Available]	2012-12-3	304	273	Panitumumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01F	TCGA-AA-A01F-D37400	A2B884E1-ED59-4356-819B-62212890077A	[Not Available]	2012-12-3	215	62	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01F	TCGA-AA-A01F-D37401	988E2E95-014A-4780-BDFE-813A1F8ACD26	[Not Available]	2012-12-3	215	62	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01F	TCGA-AA-A01F-D37402	AED5627D-9A57-44F6-82C4-CDAC2CB1EE4C	[Not Available]	2012-12-3	215	62	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01K	TCGA-AA-A01K-D37397	3A2C3BC3-3631-4F1C-BB13-DAC6A294936E	[Not Available]	2012-12-3	243	61	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01K	TCGA-AA-A01K-D37398	6796D8BC-15FF-4367-ADF9-C70A1F2D542B	[Not Available]	2012-12-3	243	61	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01K	TCGA-AA-A01K-D37399	4BEE62E4-B052-4D7B-B1AE-7020CE37EC3F	[Not Available]	2012-12-3	243	61	Oxaliplatin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01R	TCGA-AA-A01R-D37394	D951161C-677D-4A62-9684-DD8794840413	[Not Available]	2012-12-3	819	60	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01R	TCGA-AA-A01R-D37395	EF93527A-31EB-43F2-98FB-343C3AE08F54	[Not Available]	2012-12-3	819	669	Folinic acid	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01R	TCGA-AA-A01R-D37396	8EF3060A-3D3D-4F10-83A7-29CB9FDF2D8A	[Not Available]	2012-12-3	819	669	Irinotecan	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01T	TCGA-AA-A01T-D37392	45AADB1F-5899-4657-BE24-711FD3CEFC2C	[Not Available]	2012-12-3	183	60	5-Fluorouracil	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A01T	TCGA-AA-A01T-D37393	70E04694-EC9B-4596-B5C3-25BC492B1919	[Not Available]	2012-12-3	183	60	Folinic acid	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02F	TCGA-AA-A02F-D37387	F6A5DA6A-5BF9-4460-ACFE-CBA48519AAB4	[Not Available]	2012-12-3	1127	59	Folinic acid	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02F	TCGA-AA-A02F-D37388	71DCC297-9D24-453F-A455-1F3541C60CE2	[Not Available]	2012-12-3	1127	59	5-Fluorouracil	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02F	TCGA-AA-A02F-D37389	FD42DB4E-C958-48D6-BE29-86FBF6F1B815	[Not Available]	2012-12-3	1127	59	Irinotecan	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02F	TCGA-AA-A02F-D37390	FFAE6F6B-0040-4DAB-8FD5-F053839270BC	[Not Available]	2012-12-3	700	669	Oxaliplatin	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02F	TCGA-AA-A02F-D37391	9C785800-15D7-46C2-95F4-282E60286F9C	[Not Available]	2012-12-3	1096	59	Bevacizumab	Partial Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02K	TCGA-AA-A02K-D37383	284D9612-89A5-4F4D-82AD-D73C214BF630	[Not Available]	2012-12-3	275	30	Folinic acid	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02K	TCGA-AA-A02K-D37384	DA114F4F-D777-4640-A175-AC51FF4D0346	[Not Available]	2012-12-3	275	30	5-Fluorouracil	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02K	TCGA-AA-A02K-D37385	B72BBC44-9B88-4103-84CC-157C43ADFAE9	[Not Available]	2012-12-3	275	30	Irinotecan	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AA-A02K	TCGA-AA-A02K-D37386	AD48478E-2CDC-4B13-B6E6-61CAE4FEE9E9	[Not Available]	2012-12-3	275	30	Bevacizumab	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Targeted Molecular therapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AY-4070	TCGA-AY-4070-D20674	5be9b21f-28da-47a0-8c21-25f848f38f4f	[Not Available]	2012-1-19	146	64	Oxaliplatin	[Not Available]	7	[Not Available]	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-4070	TCGA-AY-4070-D20685	2a9501ce-b4e0-48b7-bcc1-39ccd2b189df	[Not Available]	2012-1-19	239	212	Irinotecan	[Not Available]	3	[Not Available]	mg/m2	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-4070	TCGA-AY-4070-D3537	68a125c7-6377-4105-866f-eef2a90ed085	[Not Available]	2010-11-18	146	64	5FU	[Not Available]	7	[Not Available]	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-4070	TCGA-AY-4070-D3554	86b293fc-06bc-4c36-956a-a2b8525fd5da	[Not Available]	2010-11-18	239	212	XELODA	[Not Available]	3	[Not Available]	mg/m2	PROGRESSION	[Not Applicable]	2	Oral	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-5543	TCGA-AY-5543-D19914	aea534a6-3b75-4e1b-b24f-56f269f3fa86	[Not Available]	2012-1-4	251	60	Oxaliplatin	[Not Available]	12	85	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-5543	TCGA-AY-5543-D19915	3fe50558-8e39-4aa2-9862-d96cf58a0c6f	[Not Available]	2012-1-4	251	60	Leucovorin	[Not Available]	12	200	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary agent	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-5543	TCGA-AY-5543-D19916	465c3779-5d7e-4817-8fd0-d76b54c4dfff	[Not Available]	2012-1-4	251	60	5FU	[Not Available]	12	2800	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-6386	TCGA-AY-6386-D21745	dcd152ef-7b0f-4554-8701-587498c2fb1b	[Not Available]	2012-2-20	245	73	5FU	[Not Available]	12	2800	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-6386	TCGA-AY-6386-D21747	9cf53d79-7012-4ee9-bd20-adcaaa841a4c	[Not Available]	2012-2-20	245	73	Leucovorin	[Not Available]	12	200	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AY-6386	TCGA-AY-6386-D21748	beee8dab-75b8-4e6b-a1a8-bd422660278c	[Not Available]	2012-2-20	245	73	Oxaliplatin	[Not Available]	12	85	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AZ-4308	TCGA-AZ-4308-D20205	309da8a6-9b7a-4a25-b3cf-72f765484963	[Not Available]	2012-1-6	195	53	Folfox-4	[Not Available]	6	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AZ-4308	TCGA-AZ-4308-D31198	fb00dbc1-fe8e-499f-a828-6f339a1095ba	[Not Available]	2012-4-25	180	50	Avastin	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4323	TCGA-AZ-4323-D30624	d2b47817-125a-48ac-85c5-bda942ea8cb8	[Not Available]	2012-4-13	[Not Available]	27	Oxaliplatin	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4615	TCGA-AZ-4615-D20214	9550a75a-dc24-400b-92c2-7665b57c6325	[Not Available]	2012-1-6	272	88	XELODA	[Not Available]	8	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	Oral	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-AZ-4616	TCGA-AZ-4616-D31069	ee6f05bf-df9b-4ced-8826-a19eafb73cc6	[Not Available]	2012-4-23	[Not Available]	122	XELODA	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4682	TCGA-AZ-4682-D30816	4f6af62d-0d2a-4536-9c92-c4fc73ff58d5	[Not Available]	2012-4-17	[Not Available]	103	Avastin	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4682	TCGA-AZ-4682-D31200	4198e4c8-9a65-40d9-9a74-0e231eb35917	[Not Available]	2012-4-25	[Not Available]	90	Camptosar	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4682	TCGA-AZ-4682-D31202	c8a170f2-d094-44f4-a6a1-e2b2b06f7ae6	[Not Available]	2012-4-25	[Not Available]	90	Folinic acid	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4682	TCGA-AZ-4682-D31203	5e969a71-8847-4099-91f4-03911df0d7ab	[Not Available]	2012-4-25	[Not Available]	90	5-FU	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-4684	TCGA-AZ-4684-D30846	2bb28cde-e6d2-4b5b-be40-2e267a44ce8b	[Not Available]	2012-4-25	[Not Available]	30	Folfox	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-6600	TCGA-AZ-6600-D34149	B95F4311-53FF-4CA7-975C-9F2B508C6EA8	[Not Available]	2012-7-31	143	121	CPT-11	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-6600	TCGA-AZ-6600-D34150	BC76525A-EFC5-4518-8284-ED321B464F5E	[Not Available]	2012-7-31	143	121	5-FU	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-6600	TCGA-AZ-6600-D34151	D03EF7A0-DCCB-4070-9D2D-89B401069535	[Not Available]	2012-7-31	143	121	Leucovorin	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-6605	TCGA-AZ-6605-D34155	06300BAA-C980-4F05-B262-22DD1912B178	[Not Available]	2012-7-31	105	56	FOLFOX	Stable Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-6606	TCGA-AZ-6606-D34173	911D9E4B-F7D6-4148-8474-7711805F5561	[Not Available]	2012-8-1	91	59	Folfiri	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-AZ-6606	TCGA-AZ-6606-D34174	410BCD90-40D4-47F1-82A9-917465D28CD4	[Not Available]	2012-8-1	153	153	5 FU	Clinical Progressive Disease	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CK-4947	TCGA-CK-4947-D14535	74525cbb-3c61-46d2-a8ee-503e66ff4ad3	[Not Available]	2011-8-2	457	457	Oxaliplatin	[Not Available]	1	85	mg/m2	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-CK-4947	TCGA-CK-4947-D14537	51ec77f6-eaf7-41d2-8888-10797b91ff48	[Not Available]	2011-8-2	457	457	Fluorouracil	[Not Available]	1	600	mg/m2	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-CK-4947	TCGA-CK-4947-D9803	3ebddb06-e6bd-46ca-ac04-5ad4941844f6	[Not Available]	2011-3-31	457	457	Folinic Acid	[Not Available]	1	200	mg/kg	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	0	mg/m2	[Not Available]
TCGA-CK-4950	TCGA-CK-4950-D9825	c3ab7778-ee30-49f8-8136-659414100e0f	[Not Available]	2011-4-1	273	48	FolFox	[Not Available]	11	2280	mg	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-CM-4750	TCGA-CM-4750-D9914	52a49370-98c2-41f8-a0bf-4f67af1d0fae	[Not Available]	2011-1-17	153	61	Oxaliplatin	[Not Available]	9	80-165	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1075	mg	[Not Available]
TCGA-CM-4750	TCGA-CM-4750-D9915	0d015d60-0914-4165-8746-4ed9f2f0a395	[Not Available]	2011-1-17	214	61	Leucovorin	[Not Available]	12	40-770	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	5690	mg/day	[Not Available]
TCGA-CM-4750	TCGA-CM-4750-D9916	0d47bdc8-bec1-4090-b4be-f7bfe1c3ea6a	[Not Available]	2011-1-17	214	61	Fluorouracil	[Not Available]	12	400-750	mg	ADJUVANT	[Not Applicable]	1	Intravesical	NO	Chemotherapy	[Not Available]	6950	mg	[Not Available]
TCGA-CM-4750	TCGA-CM-4750-D9917	f1f12f68-b591-4801-b1a8-66c57856433c	[Not Available]	2011-1-17	214	61	Fluorouracil	[Not Available]	11	2300-4650	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	41450	mg	[Not Available]
TCGA-CM-4751	TCGA-CM-4751-D16811	7814e988-0038-4dcb-8e97-89c1cbbb1f6f	[Not Available]	2011-9-26	212	61	Leucovorin Calcium	[Not Available]	12	900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	9450	mg	[Not Available]
TCGA-CM-4751	TCGA-CM-4751-D16812	38f342e3-3027-4015-9bd8-e32b4147942b	[Not Available]	2011-9-26	212	61	Oxaliplatin	[Not Available]	12	150	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1950	mg	[Not Available]
TCGA-CM-5341	TCGA-CM-5341-D16157	516885c2-a0e5-4bd5-ad56-d9d59a1c9a8a	[Not Available]	2011-9-14	273	122	Leucovorin Calcium	[Not Available]	11	600	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	4580	mg	[Not Available]
TCGA-CM-5344	TCGA-CM-5344-D15259	06418df1-95ee-4f7e-ac89-3b3af2d0490a	[Not Available]	2011-8-15	215	62	Oxaliplatin	[Not Available]	11	140	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1540	mg	[Not Available]
TCGA-CM-5344	TCGA-CM-5344-D15260	983af547-6cba-4e7d-a1c7-2ca7836f519c	[Not Available]	2011-8-15	243	62	Leucovorin	[Not Available]	12	650	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary agent	6340	mg	[Not Available]
TCGA-CM-5344	TCGA-CM-5344-D15261	82888328-8e75-4806-a3b5-fa5170d5a665	[Not Available]	2011-8-15	243	62	Fluorouracil	[Not Available]	12	650	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7800	mg	[Not Available]
TCGA-CM-5344	TCGA-CM-5344-D15262	d4db4d65-33e4-4814-99eb-8354ca36eeca	[Not Available]	2011-8-15	243	62	Fluorouracil	[Not Available]	12	2000	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	23900	mg	[Not Available]
TCGA-CM-5344	TCGA-CM-5344-D15263	c73bd755-af7e-413c-8d7d-ccd715806859	[Not Available]	2011-8-15	92	92	Filgrastim (G-CSF)	[Not Available]	1	300	ug	ADJUVANT	[Not Applicable]	1	Subcutaneous (SC)	NO	Other, specify	Ancillary agent	300	ug	[Not Available]
TCGA-CM-5344	TCGA-CM-5344-D15264	a3bae552-da95-42e8-b17c-c73532e66b4d	[Not Available]	2011-8-15	215	92	Pegfilgrastim (Peg G-CSF)	[Not Available]	10	6	mg	ADJUVANT	[Not Applicable]	1	Subcutaneous (SC)	NO	Other, specify	Ancillary agent	60	mg	[Not Available]
TCGA-CM-5860	TCGA-CM-5860-D15253	615d6a0c-5eb5-45db-9971-0001fd1f9cd8	[Not Available]	2011-8-15	184	61	Oxaliplatin	[Not Available]	11	180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1940	mg	[Not Available]
TCGA-CM-5860	TCGA-CM-5860-D15254	4ba86384-0a23-4be8-8325-35f6d8b205df	[Not Available]	2011-8-15	212	61	Leucovorin	[Not Available]	12	850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary agent	7680	mg	[Not Available]
TCGA-CM-5860	TCGA-CM-5860-D15257	adf45a83-5b88-431b-b19c-a7c9ef785048	[Not Available]	2011-8-15	212	61	Fluorouracil	[Not Available]	12	850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9800	mg	[Not Available]
TCGA-CM-5860	TCGA-CM-5860-D15258	a83b56b5-b668-4477-b60c-6df4812fea50	[Not Available]	2011-8-15	212	61	Fluorouracil	[Not Available]	12	2602.17	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	30402.17	mg	[Not Available]
TCGA-CM-5863	TCGA-CM-5863-D17062	2e32a9b2-feed-4616-84aa-8c1d6ca8acd6	[Not Available]	2011-9-30	243	92	Fluorouracil	[Not Available]	12	650	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7450	mg	[Not Available]
TCGA-CM-5863	TCGA-CM-5863-D17064	999f4791-5483-46b6-b0e8-cec6ba836469	[Not Available]	2011-9-30	243	92	Fluorouracil	[Not Available]	12	1900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	21800	mg	[Not Available]
TCGA-CM-5863	TCGA-CM-5863-D17065	93087750-78fd-430a-9c55-be528ae2e4bb	[Not Available]	2011-9-30	243	92	Leucovorin Calcium	[Not Available]	12	650	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	5000	mg	[Not Available]
TCGA-CM-5863	TCGA-CM-5863-D17066	8419859d-441b-466d-9c75-b60790d0a64b	[Not Available]	2011-9-30	243	92	Oxaliplatin	[Not Available]	12	140	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1510	mg	[Not Available]
TCGA-CM-5863	TCGA-CM-5863-D17068	8ed1a0ab-3763-46c2-9f61-21677b677973	[Not Available]	2011-9-30	243	243	Pegfilgrastim	[Not Available]	1	6	mg	ADJUVANT	[Not Applicable]	1	Subcutaneous (SC)	NO	Other, specify	Ancillary	6	mg	[Not Available]
TCGA-CM-5868	TCGA-CM-5868-D15265	231ad9ed-6fbf-41e0-b7f6-f37b39bfe7c6	[Not Available]	2011-8-15	[Not Available]	31	Floxuridine	[Not Available]	9	290	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	YES	Chemotherapy	[Not Available]	1084	mg	[Not Available]
TCGA-CM-5868	TCGA-CM-5868-D15266	91d3a944-24bc-4e79-9a0b-bcd64ee991b2	[Not Available]	2011-8-15	[Not Available]	31	Oxaliplatin	[Not Available]	9	180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	YES	Chemotherapy	[Not Available]	1100	mg	[Not Available]
TCGA-CM-5868	TCGA-CM-5868-D15267	1071fb4b-8369-4469-8f2b-3263a3bd1f05	[Not Available]	2011-8-15	[Not Available]	31	Irinotecan HCl	[Not Available]	20	260	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	YES	Chemotherapy	[Not Available]	4160	mg	[Not Available]
TCGA-CM-5868	TCGA-CM-5868-D15268	4f3182e8-b6a8-4457-b4c7-719105d866d1	[Not Available]	2011-8-15	[Not Available]	92	Dexamethasone	[Not Available]	2	25	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	YES	Other, specify	Ancillary agent	40	mg	[Not Available]
TCGA-CM-5868	TCGA-CM-5868-D15269	45dc93fc-8988-4181-bd98-c69db74aef7a	[Not Available]	2011-8-15	[Not Available]	304	Leucovorin	[Not Available]	2	850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	YES	Other, specify	Ancillary agent	1700	mg	[Not Available]
TCGA-CM-5868	TCGA-CM-5868-D15270	e1b8376b-e4a5-40b0-aa12-f2f19ef1d26a	[Not Available]	2011-8-15	[Not Available]	304	Fluorouracil	[Not Available]	2	2200	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	YES	Chemotherapy	[Not Available]	4400	mg	[Not Available]
TCGA-CM-6162	TCGA-CM-6162-D15247	e7fcc21e-a928-4e42-a8ea-b0e4c41801be	[Not Available]	2011-8-15	242	92	Oxaliplatin	[Not Available]	12	190	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2220	mg	[Not Available]
TCGA-CM-6162	TCGA-CM-6162-D15250	d84d0e07-d035-423a-8c82-89b97d740df7	[Not Available]	2011-8-15	242	92	Leucovorin	[Not Available]	12	900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary agent	7980	mg	[Not Available]
TCGA-CM-6162	TCGA-CM-6162-D15251	22258b34-c867-40d2-86f5-1c577600455d	[Not Available]	2011-8-15	242	92	Fluorouracil	[Not Available]	12	850-900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10500	mg	[Not Available]
TCGA-CM-6162	TCGA-CM-6162-D15252	d1f5f997-c18a-4c1a-a070-423e4d0edcc0	[Not Available]	2011-8-15	242	92	Fluorouracil	[Not Available]	12	2700	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	31600	mg	[Not Available]
TCGA-CM-6169	TCGA-CM-6169-D15215	d843573b-abb6-4375-b320-65b6e417f688	[Not Available]	2011-8-15	151	92	Oxaliplatin	[Not Available]	6	180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1080	mg	[Not Available]
TCGA-CM-6169	TCGA-CM-6169-D15236	7997d2ef-1c60-43b9-9096-e0c4fe13dea2	[Not Available]	2011-8-15	243	92	Leucovorin	[Not Available]	12	850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary agent	7050	mg	[Not Available]
TCGA-CM-6169	TCGA-CM-6169-D15238	11bdf997-2b4c-4fd3-a358-3621721d4fa8	[Not Available]	2011-8-15	243	92	Fluorouracil	[Not Available]	12	850	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10200	mg	[Not Available]
TCGA-CM-6169	TCGA-CM-6169-D15240	bcc4b8af-2a42-4ea6-b631-67417436a9e2	[Not Available]	2011-8-15	243	92	Fluorouracil	[Not Available]	12	2600	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	31200	mg	[Not Available]
TCGA-CM-6172	TCGA-CM-6172-D15207	1c92cd0a-a3ad-417d-b9f2-5ee194656f03	[Not Available]	2011-8-15	242	90	Leucovorin	[Not Available]	12	700	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary agent	6890	mg	[Not Available]
TCGA-CM-6172	TCGA-CM-6172-D15210	4ab077b9-0d4a-4eba-91a6-afb6b7dea381	[Not Available]	2011-8-15	242	90	Fluorouracil	[Not Available]	12	700	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7950	mg	[Not Available]
TCGA-CM-6172	TCGA-CM-6172-D15211	fede8ba2-c2c4-4f42-93f9-5599ab87d56d	[Not Available]	2011-8-15	242	90	Fluorouracil	[Not Available]	12	2100	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	24000	mg	[Not Available]
TCGA-CM-6675	TCGA-CM-6675-D17052	c2c0fc72-b0b4-41c1-83bf-df641b19a714	[Not Available]	2012-4-19	183	30	Fluorouracil	[Not Available]	12	900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9400	mg	[Not Available]
TCGA-CM-6675	TCGA-CM-6675-D17053	95f85e67-bcf8-41f4-ab52-2987bb657f7f	[Not Available]	2011-4-19	183	30	Fluorouracil	[Not Available]	12	2800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	32600	mg	[Not Available]
TCGA-CM-6675	TCGA-CM-6675-D17055	7ca01e01-187e-4151-8bb8-ce64a784aa3b	[Not Available]	2011-4-19	183	30	Leucovorin Calcium	[Not Available]	12	900	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Ancillary	9400	mg	[Not Available]
TCGA-CM-6675	TCGA-CM-6675-D17056	561e1b28-4f4f-4a49-ac98-773ff5f37469	[Not Available]	2011-9-30	152	30	Oxaliplatin	[Not Available]	10	190	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1780	mg	[Not Available]
TCGA-CM-6675	TCGA-CM-6675-D17058	c2e7d5c5-7b1f-4a5c-9df4-a5a48969c93c	[Not Available]	2011-9-30	152	60	Pegfilgrastim	[Not Available]	7	6	mg	ADJUVANT	[Not Applicable]	1	Subcutaneous (SC)	NO	Other, specify	Ancillary	42	mg	[Not Available]
TCGA-CM-6675	TCGA-CM-6675-D30935	d1a17bb6-9a68-4c16-9360-01cd3518b8d4	[Not Available]	2012-4-19	[Not Available]	337	Fluorouracil	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CM-6675	TCGA-CM-6675-D30939	e3a83403-6a75-451b-a0e6-0cbd8e0635a8	[Not Available]	2012-4-19	[Not Available]	337	IRINOtecan HCl	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CM-6675	TCGA-CM-6675-D30940	e24f390b-4610-43a6-8399-34d5373fb519	[Not Available]	2012-4-19	[Not Available]	337	Leucovorin Calcium	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CM-6675	TCGA-CM-6675-D30942	a3363539-73b2-432d-aaaa-e0638f2cc5df	[Not Available]	2012-4-19	[Not Available]	366	Cetuximab	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CM-6675	TCGA-CM-6675-D30943	63a50739-dc5b-40cd-90f2-b709c14dfde0	[Not Available]	2012-4-19	[Not Available]	337	Floxuridine	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CM-6678	TCGA-CM-6678-D17049	01518ad8-5c28-40d7-8e5f-2d15a4df5355	[Not Available]	2012-4-19	214	0	Floxuridine	[Not Available]	7	170	mg	ADJUVANT	[Not Applicable]	1	Intrahepatic	NO	Chemotherapy	[Not Available]	475	mg	[Not Available]
TCGA-CM-6678	TCGA-CM-6678-D17050	0452e18b-530a-40c8-bd25-d973c1784af8	[Not Available]	2012-4-19	91	30	Oxaliplatin	[Not Available]	7	130	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	770	mg	[Not Available]
TCGA-CM-6678	TCGA-CM-6678-D17051	f1e0900b-3a55-4d01-b8ed-d23892afb723	[Not Available]	2012-4-19	214	30	Irinotecan HCL	[Not Available]	12	200	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2040	mg	[Not Available]
TCGA-CM-6678	TCGA-CM-6678-D30951	e903ec03-d66a-4f5b-87a8-e1e78e0e79e6	[Not Available]	2012-4-19	275	275	Floxuridine	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-CM-6678	TCGA-CM-6678-D30953	fbd5870c-73a8-401f-a792-4a7aeda61922	[Not Available]	2012-4-19	306	275	IRINOtecan HCl	[Unknown]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-D5-5538	TCGA-D5-5538-D13828	20ccac76-619d-4720-a197-8a648eb7ef26	[Not Available]	2011-6-20	282	22	Calcium Foliatum, fluorouracilum, oxaliplatinum, dexamethassone	[Not Available]	12	Calcium Foliatum 708mg, fluorouracilum 3950mg, oxaliplatinum 150,45mg, dexamethassone 8mg	mg	ADJUVANT	[Not Applicable]	FOL FOX4	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	mg	[Not Available]
TCGA-D5-5539	TCGA-D5-5539-D20730	cfa250cc-1c8d-4e9f-8385-fe6426cd2c8c	[Not Available]	2012-1-19	195	38	5-FU	[Not Available]	9	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-D5-5541	TCGA-D5-5541-D13833	a81be0b5-fa86-4b78-91df-05546d47d69c	[Not Available]	2011-7-4	279	19	Calcium Foliatum, fluorouracilum, oxaliplatinum, dexamethassone	[Not Available]	12	Calcium Foliatum 768mg, fluorouracilum 3890mg, oxaliplatinum 163,2mg, dexamethassone 8mg	mg	ADJUVANT	[Not Applicable]	FOL FOX4	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	mg	[Not Available]
TCGA-D5-6529	TCGA-D5-6529-D28929	8f6e7fb1-f1f1-4c84-a677-d71f8713a584	[Not Available]	2012-3-2	[Not Available]	502	oxaliplatinum+ 5-FU	[Not Available]	9	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	[Not Available]	Intravenous (IV)	YES	Chemotherapy	[Not Available]	1530+36000	mg	[Not Available]
TCGA-D5-6536	TCGA-D5-6536-D28926	16cf1090-853e-4a5c-8ba5-6eb873d29def	[Not Available]	2012-2-3	[Not Available]	539	5-FU	[Not Available]	1	425	mg/m2/day	PALLIATIVE	[Not Applicable]	[Not Available]	Intravenous (IV)	YES	Chemotherapy	[Not Available]	3750	mg	[Not Available]
TCGA-D5-6538	TCGA-D5-6538-D28625	fe993031-2966-48c0-af72-b6e31f2652ec	[Not Available]	2012-2-27	[Not Available]	23	XELODA	[Not Available]	[Not Available]	500mg	mg	ADJUVANT	[Not Applicable]	[Not Available]	Oral	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-F4-6460	TCGA-F4-6460-D29825	24A4BE6E-8504-46A7-9FE6-9F601A1E0AAA	[Not Available]	2012-3-29	228	26	Capecitabine	[Not Available]	10	4	g/day	ADJUVANT	[Not Applicable]	[Not Available]	Oral	NO	Chemotherapy	[Not Available]	640	[Not Available]	[Not Available]
TCGA-F4-6460	TCGA-F4-6460-D29827	E00AA1AF-9E7F-47DD-BA9D-3662DCE2FD87	[Not Available]	2012-3-29	137	26	Oxaliplatin	[Not Available]	6	150	mg/day	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	NO	Chemotherapy	[Not Available]	900	mg	[Not Available]
TCGA-F4-6460	TCGA-F4-6460-D29828	DE75E343-2A6A-4264-A2B7-1F99A217E0C7	[Not Available]	2012-3-29	[Not Available]	313	Raltitrexed	[Not Available]	5	4	g/day	ADJUVANT	[Not Applicable]	[Not Available]	Intravenous (IV)	YES	Chemotherapy	[Not Available]	20	[Not Available]	[Not Available]
TCGA-F4-6805	TCGA-F4-6805-D35065	8EEA3753-54B7-4A29-9F52-588A974F7AA9	[Not Available]	2012-9-14	110	29	Xeloda	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-F4-6807	TCGA-F4-6807-D35070	7599BE98-8FE6-4E14-A6BF-8F31624CF90F	[Not Available]	2012-9-14	284	72	Xeloda	Complete Response	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	YES
TCGA-G4-6293	TCGA-G4-6293-D21800	b280e2a2-cbfb-45dd-9277-bb4a0c42f558	[Not Available]	2012-1-19	235	25	Fluorouracil	[Not Available]	4	500	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2000	mg/m2	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22036	f5cb0992-8578-4bd2-ba86-8513ec065440	[Not Available]	2012-2-21	[Completed]	0	Avastin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22038	ae9c5e2a-c767-42b1-a16a-9c9f73074e4d	[Not Available]	2012-2-21	349	0	Leucovorin	[Not Available]	20	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22039	7101e3e7-3beb-48f7-9c4e-8aeb5c76bc14	[Not Available]	2012-2-21	349	0	Oxaliplatin	[Not Available]	20	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22041	0ea0145e-3a7d-40d6-b958-54abb60540af	[Not Available]	2012-2-21	349	0	Fluorouracil	[Not Available]	20	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22042	5a510a56-eb65-4936-9e48-2d8ecdb51c1f	[Not Available]	2012-2-21	699	535	Leucovorin	[Not Available]	13	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22043	4801f827-3069-49da-9725-5b242a26f836	[Not Available]	2012-2-21	699	535	Fluorouracil	[Not Available]	13	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22044	dcdccc6a-81a7-4b9d-bf04-6561175b1d1a	[Not Available]	2012-2-21	699	535	Oxaliplatin	[Not Available]	13	55	mg/m2	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	715	mg/m2	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22045	1a072c20-b6cb-46c5-af5d-9dccfd8d1afb	[Not Available]	2012-2-21	699	699	Irinotecan	[Not Available]	1	125	mg/m2	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	125	mg/m2	[Not Available]
TCGA-G4-6294	TCGA-G4-6294-D22046	fc42c0f1-55d8-42a0-8845-2934c2f3ec16	[Not Available]	2012-2-21	699	699	Erbitux	[Not Available]	1	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22068	bc52a962-29c2-4ed2-bea0-fe0240f2aca4	[Not Available]	2012-1-19	102	32	Avastin	[Not Available]	[Not Available]	5	mg/kg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22071	8425101a-756c-410d-81a8-2076b80de3bb	[Not Available]	2012-1-19	102	32	Oxaliplatin	[Not Available]	[Not Available]	85	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22073	26aae8b9-b217-4ae4-84d2-20eb58eaa2b2	[Not Available]	2012-1-19	102	32	Fluorouracil	[Not Available]	[Not Available]	400	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22074	6ab9bc08-f684-4502-8451-741d5a9dbff9	[Not Available]	2012-1-19	102	32	Leucovorin	[Not Available]	[Not Available]	400	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22076	991cc478-d3ed-4616-beae-0cc297dd9613	[Not Available]	2012-1-19	726	564	Cetuximab	[Not Available]	23	760	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	11210	mg	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22079	c9ab9ffe-f904-4dfa-914c-0e8d4b3ed184	[Not Available]	2012-1-19	719	564	Irinotecan	[Not Available]	12	342	mg	PROGRESSION	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	4104	mg	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22080	f0c7c99e-319d-4edb-b480-dd3e75e87b4e	[Not Available]	2012-1-19	1180	1041	Bevacizumab	[Not Available]	10	445	mg	RECURRENCE	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	4310	mg	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22082	2163c50a-6a57-4240-8eab-f6502f8bb1aa	[Not Available]	2012-1-19	1076	1041	Oxaliplatin	[Not Available]	3	170	mg	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	510	mg	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22084	f7189321-dcef-43c0-9505-44974a7d1aae	[Not Available]	2012-1-19	1180	1041	Fluorouracil	[Not Available]	10	800	mg	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7900	mg	[Not Available]
TCGA-G4-6297	TCGA-G4-6297-D22086	f780471b-7abe-465c-a68a-8cdc3c54bbf3	[Not Available]	2012-1-19	1180	1041	Leucovorin	[Not Available]	10	800	mg	RECURRENCE	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	7900	mg	[Not Available]
TCGA-G4-6298	TCGA-G4-6298-D21967	4b271363-fb42-41fc-ba0a-4a1866ebd1d7	[Not Available]	2012-1-20	461	411	Erbitux	[Not Available]	4	440	mg	PROGRESSION	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1760	mg	[Not Available]
TCGA-G4-6298	TCGA-G4-6298-D21968	b201fb4c-7422-447a-87c1-c46516ed2b91	[Not Available]	2012-1-20	461	411	Irinotecan	[Not Available]	4	176	mg	PROGRESSION	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	704	mg	[Not Available]
TCGA-G4-6299	TCGA-G4-6299-D22029	f7f479e8-c97f-4318-841c-4093a7451dfc	[Not Available]	2012-1-20	363	38	Bevacizumab	[Not Available]	24	5	mg/kg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Phase III Clinial Trial	120	mg/kg	[Not Available]
TCGA-G4-6299	TCGA-G4-6299-D22030	7c7ee768-9568-4ec4-9026-3ce737ed05dc	[Not Available]	2012-1-20	192	38	Leocovorin	[Not Available]	12	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Phase III Clinial Trial	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6299	TCGA-G4-6299-D22032	cdfa4fa2-4682-4fc8-883a-185c52a8986d	[Not Available]	2012-1-20	192	38	Oxaliplatin	[Not Available]	12	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Phase III Clinical Trial	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6299	TCGA-G4-6299-D22033	3a112e40-6f15-46f9-a153-7cf96e71c8f4	[Not Available]	2012-1-20	192	38	Fluorouracil	[Not Available]	12	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Other, specify	Phase III Clinical Trial	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21600	30f4a7a0-2e8d-4001-b5ff-cc4797c7fd66	[Not Available]	2012-1-23	670	516	Leucovorin	[Not Available]	6	660	mg	PROGRESSION	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3960	mg	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21601	fbdd2907-7af7-4844-b7e9-b01ee80daa88	[Not Available]	2012-1-23	670	516	Oxaliplatin	[Not Available]	6	165	mg	PROGRESSION	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	990	mg	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21602	d5338126-8849-4359-bd0e-9639362668d3	[Not Available]	2012-1-23	670	516	5-FU	[Not Available]	6	660	mg	PROGRESSION	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3960	mg	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21603	57970f69-f63f-427e-bf68-86d90b0f5ac8	[Not Available]	2012-1-23	1431	884	Avastin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	2	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21604	469d1453-719a-4bec-bf80-abd497cca359	[Not Available]	2012-1-23	1431	884	Leucovorin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	2	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21605	7a35095d-25fa-4780-95aa-88c2c4032d95	[Not Available]	2012-1-23	1431	884	5-FU	[Not Available]	[Not Available]	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	2	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21717	34bd5fb4-ebfa-4d5b-9ae9-96be74c05bf1	[Not Available]	2012-1-23	1584	1431	Leucovorin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	3	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21720	fa5d0604-06c3-454e-9925-da7bf7285324	[Not Available]	2012-1-23	1584	1431	Irinotecan	[Not Available]	[Not Available]	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	3	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21722	8513635f-8463-49de-83f2-6c54d479b728	[Not Available]	2012-1-23	1584	1431	5-FU	[Not Available]	[Not Available]	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	3	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21725	b33e676e-a8c1-4fa6-9015-db6d44507b9d	[Not Available]	2012-1-23	1826	1584	Erbitux	[Not Available]	12	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	4	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21727	d26c7bb7-87f7-4960-9ed4-8ef58ac71e95	[Not Available]	2012-1-23	1826	1584	Irinotecan	[Not Available]	12	[Not Available]	[Not Available]	PROGRESSION	[Not Applicable]	4	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6303	TCGA-G4-6303-D21789	c92c9a04-8347-4909-960b-0f4878f27b08	[Not Available]	2012-1-23	1994	1840	Oxaliplatin	[Not Available]	10	145	mg	PROGRESSION	[Not Applicable]	5	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1450	mg	[Not Available]
TCGA-G4-6304	TCGA-G4-6304-D21873	dd809433-8215-46dc-84c1-61087ef5c99b	[Not Available]	2012-2-6	258	46	Fluorouracil	[Not Available]	[Not Available]	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6304	TCGA-G4-6304-D21877	3ebc93a4-f712-4cce-bf92-ac8e144d6365	[Not Available]	2012-2-6	258	46	Oxaliplatin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6304	TCGA-G4-6304-D21879	acd0a481-2c9c-4f44-8241-5c356396a8e8	[Not Available]	2012-2-6	258	46	Leucovorin	[Not Available]	[Not Available]	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6307	TCGA-G4-6307-D21941	bcf0997e-092d-4457-9be6-90cb82e51bd4	[Not Available]	2012-1-25	229	47	Fluorouracil	[Not Available]	12	720	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	8640	mg	[Not Available]
TCGA-G4-6307	TCGA-G4-6307-D21942	716a76ab-cae0-4593-820b-39fdc2d598d4	[Not Available]	2012-1-25	187	47	Oxaliplatin	[Not Available]	8	153	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1056	mg	[Not Available]
TCGA-G4-6307	TCGA-G4-6307-D21943	14d134ef-0304-4361-99b3-d74891f94c8a	[Not Available]	2012-1-25	229	47	Leucovorin	[Not Available]	12	720	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	8640	mg	[Not Available]
TCGA-G4-6309	TCGA-G4-6309-D21947	0104d92b-90fe-42c8-9f02-dd916ce7b46f	[Not Available]	2012-2-6	254	73	Xeloda	[Not Available]	8	3600	mg/day	ADJUVANT	[Not Applicable]	1	Oral	NO	Chemotherapy	[Not Available]	355600	mg	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21928	cb1310c0-860e-4d70-a72e-96e0fdc38613	[Not Available]	2012-1-25	75	33	Oxaliplatin	[Not Available]	4	180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	684	mg	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21933	892163e8-62fc-4fbe-a0ed-712508e46f84	[Not Available]	2012-1-25	75	33	Leucovorin	[Not Available]	4	840	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3200	mg	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21934	ced5bc62-7f2c-48e6-b830-f6f4a131fb03	[Not Available]	2012-1-25	75	33	5-FU	[Not Available]	4	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	1	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21935	5e979430-9982-4b1b-8485-4805ba371049	[Not Available]	2012-1-25	131	89	Xeloda	[Not Available]	[Not Available]	3000	mg/day	ADJUVANT	[Not Applicable]	2	Oral	NO	Chemotherapy	[Not Available]	90000	mg	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21936	1b57d686-2c1f-43ea-a842-1360b246b826	[Not Available]	2012-1-25	193	152	Oxaliplatin	[Not Available]	4	170	mg	ADJUVANT	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	680	mg	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21937	7648d80e-9205-4675-b34d-f82fa7ab36a7	[Not Available]	2012-1-25	193	152	Leucovorin	[Not Available]	4	800	mg	ADJUVANT	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3200	mg	[Not Available]
TCGA-G4-6310	TCGA-G4-6310-D21938	477f4c3c-ef6e-4873-9d95-3b1aa1e0d9a9	[Not Available]	2012-1-25	193	152	5-FU	[Not Available]	4	[Not Available]	[Not Available]	ADJUVANT	[Not Applicable]	3	[Not Available]	NO	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	[Not Available]
TCGA-G4-6311	TCGA-G4-6311-D21921	47dfca4c-93b9-421c-be8f-617d251452ae	[Not Available]	2012-1-27	148	36	Oxaliplatin	[Not Available]	9	152	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1369	mg	[Not Available]
TCGA-G4-6311	TCGA-G4-6311-D21922	f10cb485-4558-454a-9a1e-905a5cabba57	[Not Available]	2012-1-27	190	36	Fluorouracil	[Not Available]	12	400	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	4800	mg/m2	[Not Available]
TCGA-G4-6311	TCGA-G4-6311-D21923	1e9c5fe9-4666-4187-ab0c-6c2b09dc240a	[Not Available]	2012-1-27	190	36	Leucovorin	[Not Available]	12	400	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	4800	mg/m2	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21810	17ca7309-e359-4399-9b2f-67b7fbe11468	[Not Available]	2012-2-9	209	48	Leucovorin	[Not Available]	12	756	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	8976	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21813	d2536ed5-5f4a-4cda-a592-2ff4aac998f2	[Not Available]	2012-2-9	181	48	Oxaliplatin	[Not Available]	10	160	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1577	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21814	e59c220a-3767-418d-a106-a86a8ac11057	[Not Available]	2012-2-9	209	103	Fluorouracil	[Not Available]	8	752	mg	ADJUVANT	[Not Applicable]	2	Intravenous (IV)	NO	Chemotherapy	[Not Available]	6000	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21815	7e1069d3-9265-49bc-a9dd-2004971ed7bb	[Not Available]	2012-2-9	561	337	Bevacizumab	[Not Available]	17	386	mg	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	6404	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21817	cf59cdd0-7a94-4432-90cf-15a5b6c41bc2	[Not Available]	2012-2-9	561	337	Leucovorin	[Not Available]	17	740	mg	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	12464	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21819	25e50ae8-9511-4f12-b1c4-73a2e8b2b2cc	[Not Available]	2012-2-9	561	337	Irinotecan	[Not Available]	17	240	mg	PROGRESSION	[Not Applicable]	3	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3874	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21821	6b644f7b-34e8-4860-ab40-d199dd3202cd	[Not Available]	2012-2-9	1045	954	Cetuximab	[Not Available]	7	825	mg	PROGRESSION	[Not Applicable]	4	Intravenous (IV)	NO	Chemotherapy	[Not Available]	5765	mg	[Not Available]
TCGA-G4-6314	TCGA-G4-6314-D21822	1b0ba903-4ca7-483f-bf97-9e3138b7afdc	[Not Available]	2012-2-9	1045	954	Irinotecan	[Not Available]	7	165	mg	PROGRESSION	[Not Applicable]	4	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1085	mg	[Not Available]
TCGA-G4-6315	TCGA-G4-6315-D21985	9a8027b9-bdd9-4354-a3df-7c8b335184b3	[Not Available]	2012-1-27	180	40	Fluorouracil	[Not Available]	10	672	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	6742	mg	[Not Available]
TCGA-G4-6315	TCGA-G4-6315-D21990	ac5b93fb-3aa7-4ff2-8699-5acfe146f59e	[Not Available]	2012-1-27	138	40	Oxaliplatin	[Not Available]	8	143	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1136	mg	[Not Available]
TCGA-G4-6315	TCGA-G4-6315-D21992	fcc343e4-8a19-46af-93e6-fe2c4ef5ad4b	[Not Available]	2012-1-27	180	40	Bevacizumab	[Not Available]	11	298	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	3267	mg	[Not Available]
TCGA-G4-6317	TCGA-G4-6317-D21906	4000a702-021c-48f2-bfa2-e3c52473cf59	[Not Available]	2012-1-30	200	47	Fluorouracil	[Not Available]	12	800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9664	mg	[Not Available]
TCGA-G4-6317	TCGA-G4-6317-D21907	8a1ce59a-d27d-4bf6-b512-3c41d7ee9704	[Not Available]	2012-1-30	200	47	Oxaliplatin	[Not Available]	11	170	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1882	mg	[Not Available]
TCGA-G4-6317	TCGA-G4-6317-D21909	f832e4e9-adbc-47e3-8ded-4aa8a47b947b	[Not Available]	2012-1-30	200	47	Leucovorin	[Not Available]	12	800	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9600	mg	[Not Available]
TCGA-G4-6320	TCGA-G4-6320-D21911	cc241491-1bbe-4a4e-bce5-52b8b63d0f39	[Not Available]	2012-1-30	145	41	Oxaliplatin	[Not Available]	8	227	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1600	mg	[Not Available]
TCGA-G4-6320	TCGA-G4-6320-D21913	536049c4-8854-4618-8702-adba0c21b59c	[Not Available]	2012-1-30	209	41	Fluorouracil	[Not Available]	12	400	mg/m2	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	4800	mg/m2	[Not Available]
TCGA-G4-6320	TCGA-G4-6320-D21914	2b3677bc-4ef6-4226-ac39-22c5a2c4e2cd	[Not Available]	2012-1-30	209	41	Leucovorin	[Not Available]	12	1068	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	12816	mg	[Not Available]
TCGA-G4-6321	TCGA-G4-6321-D21917	2de2d207-7fac-4c6a-b0b3-57c575eff4f3	[Not Available]	2012-2-22	242	103	Oxaliplatin	[Not Available]	11	175	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	1890	mg	[Not Available]
TCGA-G4-6321	TCGA-G4-6321-D21918	939cf32b-c067-4fe7-b0d4-5ab549c56393	[Not Available]	2012-1-30	256	103	Fluorouracil	[Not Available]	12	824	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9680	mg	[Not Available]
TCGA-G4-6321	TCGA-G4-6321-D21919	cdfb2842-633d-48b2-8a2b-47d9c6ffa86e	[Not Available]	2012-1-30	256	103	Leucovorin	[Not Available]	12	824	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	9680	mg	[Not Available]
TCGA-G4-6322	TCGA-G4-6322-D21961	609871f8-cee5-4029-bf5c-1f625ca7472f	[Not Available]	2012-1-30	189	36	Oxaliplatin	[Not Available]	12	180	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	2148	mg	[Not Available]
TCGA-G4-6322	TCGA-G4-6322-D21962	48474a61-d438-4c32-8b45-e077144102f9	[Not Available]	2012-1-30	189	36	Fluorouracil	[Not Available]	12	844	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10096	mg	[Not Available]
TCGA-G4-6322	TCGA-G4-6322-D21963	9f9a389b-abde-4403-819f-44e648bcc4b2	[Not Available]	2012-1-30	189	36	Leucovorin	[Not Available]	12	844	mg	ADJUVANT	[Not Applicable]	1	Intravenous (IV)	NO	Chemotherapy	[Not Available]	10096	mg	[Not Available]
TCGA-NH-A50V	TCGA-NH-A50V-D40977	86D33EB0-1853-4CA8-9F9A-BF0D9C9B2279	[Not Available]	2013-3-8	[Not Available]	22	fluorouracil	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
TCGA-NH-A50V	TCGA-NH-A50V-D40978	1543E54E-1A13-4C79-B149-E1B59A6882F6	[Not Available]	2013-3-8	[Not Available]	53	oxaliplatin	[Not Applicable]	[Not Available]	[Not Available]	[Not Available]	[Not Available]	[Not Applicable]	[Not Available]	[Not Available]	YES	Chemotherapy	[Not Available]	[Not Available]	[Not Available]	NO
